JA Clinical Reports (Feb 2024)

Remimazolam in perioperative management of Eisenmenger syndrome: a case report

  • Kazuya Hashimoto,
  • Tsuguhiro Matsumoto,
  • Toshiyuki Mizota,
  • Shinichi Kai,
  • Moritoki Egi

DOI
https://doi.org/10.1186/s40981-024-00692-6
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 4

Abstract

Read online

Abstract Background Eisenmenger syndrome (ES) is characterized by severe and irreversible pulmonary hypertension stemming from an uncorrected intracardiac shunt of significant size. The imbalance between systemic and pulmonary artery pressures predisposes patients with ES to the risk of cardiac arrest. Remimazolam has caused less circulatory depression, which may be advantageous for ES. However, no studies reported the use of remimazolam in perioperative ES management. Case presentation A 45-year-old female patient with ES derived from a ventricular septal defect was scheduled to undergo bilateral adnexectomy for an ovarian tumor. Her oxygen saturation was 80% with 3 L/min oxygen at rest, and her pulmonary and systemic flow ratio was 0.53. She underwent general anesthesia with remimazolam, and intraoperative hemodynamics was stable without hypotension or reduced oxygen saturation. Conclusions Our successful management of ovarian tumor surgery in a patient with ES using remimazolam reveals its potential effectiveness in perioperative care.

Keywords